CERO THERAPEUTICS HOLDINGS, INC. Sales and Excise Tax Payable
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Sales and Excise Tax Payable of $56.39 thousand as of 2023-12-31, per its 10-K filed 2024-04-02.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent · last filed 2024-04-02
- 2023-12-31: Sales and Excise Tax Payable $56.39K.
- 2023-09-30: Sales and Excise Tax Payable $56.39K.
| Period end | Sales and Excise Tax Payable |
|---|---|
| 2023-12-31 | $56.39K 10-K · filed 2024-04-02 |
| 2023-09-30 | $56.39K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |